Patent details
970039 Product Name: [1R-[1a(Z),2ß(R*),3a,5a]]-7-[3,5-Dihydroxy-2-(3-hydroxy-5- fenylpentyl)cyclopentyl]-5-hepteenzuur, desgewenst in de vorm van een zout of een ester, in het bijzonder Latanoprostum
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 970039
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP0364417
- Status:
- Expired Art. 14 (a) of the EC Regulations
- Application number:
- 970039
- Procedural language:
- Dutch
- First Applicant Residence Country:
Paediatric Extension
- SPC Extension Filing Date:
- 13/01/2011
- SPC Extension Agent/Owner Name:
- ir. A. Blokland c.s. , Pfizer Health AB
- SPC Extension Status:
- Extension Granted
- SPC Extension Grant Date:
- 27/01/2011
- SPC Extension Request Refusal Date:
- SPC Extension Revocation Date:
Marketing Authorization
1
- Marketing Authorization Number:
- 12716
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 18/07/1996
- Marketing Authorization Country:
- Sweden (SE)
2
- Marketing Authorization Number:
- RVG 21304
- Marketing Authorization Type:
- National/EU
- Marketing Authorization Date:
- 10/06/1997
- Marketing Authorization Country:
- Netherlands (NL)
Dates
- Filing date:
- 12/11/1997
- First Marketing Authorization date:
- 18/07/1996
- Grant date:
- 12/02/1998
- Activation date:
- 06/09/2009
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 12/11/1997
- SPC/SPC Extension Expiration Date:
- 17/01/2012
- Lapsed By Expiration Date:
- 18/01/2012
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 11/11/2010
- Name:
- Pfizer Health AB
- Address:
- --, 191 90, Sollentuna, Sweden (SE)
Historical Applicant/holder
- From:
- 03/12/2003
- To:
- 11/11/2010
- Name:
- Pharmacia Aktiebolag
- Address:
- --, 191 90, Sollentuna, Sweden (SE)
- From:
- 12/11/1997
- To:
- 03/12/2003
- Name:
- Pharmacia & Upjohn Aktiebolag
- Address:
- 112 87 Stockholm, -, Sweden (SE)
Agent
- Name:
- ir. A. Blokland c.s.
- From:
- 12/11/1997
- Address:
- Algemeen Octrooi- en Merkenbureau B.V. Postbus 645, 5600 AP, Eindhoven, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 2012/06
- Publication date:
- 08/02/2012
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- MED
- Journal edition number:
- 2011/06
- Publication date:
- 09/02/2011
- Description:
- Other communications
3
- Bulletin Heading:
- MED
- Journal edition number:
- 2011/03
- Publication date:
- 19/01/2011
- Description:
- Other communications
4
- Bulletin Heading:
- MED
- Journal edition number:
- 2010/40
- Publication date:
- 24/11/2010
- Description:
- Other communications
5
- Bulletin Heading:
- MED
- Journal edition number:
- 2004/02
- Publication date:
- 02/02/2004
- Description:
- Other communications
6
- Bulletin Heading:
- SPC
- Journal edition number:
- 1998/04
- Publication date:
- 01/04/1998
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
7
- Bulletin Heading:
- SPC
- Journal edition number:
- 1998/02
- Publication date:
- 02/02/1998
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name
- Deed Number:
- 013782-A013782-1
- Date Registered:
- 11/11/2010
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. M.F.J.M. Ketelaars c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name
- Deed Number:
- 43473-A043473-1
- Date Registered:
- 03/12/2003
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. A. Blokland c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Registration Summons/Subpoena
- Change Kind/ Decision Type:
- For Invalidity declaration
- Deed Number:
- 41110-A041110-1
- Date Registered:
- 18/09/2002
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- Ir. B.J. 't Jong c.s.
- Journal Edition Number:
- Text:
- Dagvaarding nietigverklaring op verzoek van Allergan Inc., Irvine, Californië, Ver. St. van Amerika van Eur (NL) octrooi 0364417 op naam van Pharmacia & Upjohn Aktiebolag te Stockholm, Zweden. Inschrijving verzocht door R.E.P. de Ranitz, Octrooibureau Arnold & Siedsma te Den Haag. Zie verder de akte.
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 08/07/2011
- Last Annual Fee Paid Number:
- 23
- Last Annual Fee Paid Amount:
- 2000 Euro
- Payer:
- Master Data Center
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 17/01/2011 | Incoming Correspondence Paper | Other | 4 | /9/3/0/0/7/0400970039/docs/970039_3_incomingcorrespondencepaper20110117.pdf | ||
| 17/01/2011 | Incoming Correspondence Paper | Other | 3 | /9/3/0/0/7/0400970039/docs/970039_6_incomingcorrespondencepaper20110117.pdf | ||
| 17/01/2011 | Incoming Correspondence Paper | Other | 4 | /9/3/0/0/7/0400970039/docs/970039_8_incomingcorrespondencepaper20110117.pdf | ||
| 17/01/2011 | Incoming Correspondence Paper | Other | 6 | /9/3/0/0/7/0400970039/docs/970039_10_incomingcorrespondencepaper20110117.pdf | ||
| 17/01/2011 | Incoming Correspondence Paper | Other | 9 | /9/3/0/0/7/0400970039/docs/970039_12_incomingcorrespondencepaper20110117.pdf | ||
| 17/01/2011 | General | 1 | /9/3/0/0/7/0400970039/docs/970039_16_spc-documents20110117.pdf | |||
| 17/01/2011 | Incoming Correspondence Paper | Other | 33 | /9/3/0/0/7/0400970039/docs/970039_23_incomingcorrespondencepaper20110117.pdf | ||
| 17/01/2011 | Incoming Correspondence Paper | Other | 2 | /9/3/0/0/7/0400970039/docs/970039_27_incomingcorrespondencepaper20110117.pdf | ||
| 17/01/2011 | Incoming Correspondence Paper | Other | 12 | /9/3/0/0/7/0400970039/docs/970039_28_incomingcorrespondencepaper20110117.pdf | ||
| 17/01/2011 | Incoming Correspondence Paper | Other | 4 | /9/3/0/0/7/0400970039/docs/970039_30_incomingcorrespondencepaper20110117.pdf | ||
| 17/01/2011 | Incoming Correspondence Paper | Other | 14 | /9/3/0/0/7/0400970039/docs/970039_34_incomingcorrespondencepaper20110117.pdf | ||
| 17/01/2011 | Incoming Correspondence Paper | Other | 3 | /9/3/0/0/7/0400970039/docs/970039_36_incomingcorrespondencepaper20110117.pdf | ||
| 12/01/2011 | Outgoing Correspondence | Outgoing Letter | 1 | /9/3/0/0/7/0400970039/docs/970039_32_outgoingcorrespondence20110112.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 6 | /9/3/0/0/7/0400970039/docs/970039_1_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 12 | /9/3/0/0/7/0400970039/docs/970039_2_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 2 | /9/3/0/0/7/0400970039/docs/970039_4_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 6 | /9/3/0/0/7/0400970039/docs/970039_5_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 2 | /9/3/0/0/7/0400970039/docs/970039_7_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 2 | /9/3/0/0/7/0400970039/docs/970039_9_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 2 | /9/3/0/0/7/0400970039/docs/970039_11_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 1 | /9/3/0/0/7/0400970039/docs/970039_13_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 2 | /9/3/0/0/7/0400970039/docs/970039_14_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 1 | /9/3/0/0/7/0400970039/docs/970039_15_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /9/3/0/0/7/0400970039/docs/970039_17_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 2 | /9/3/0/0/7/0400970039/docs/970039_18_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 7 | /9/3/0/0/7/0400970039/docs/970039_19_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 16 | /9/3/0/0/7/0400970039/docs/970039_20_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 1 | /9/3/0/0/7/0400970039/docs/970039_21_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 3 | /9/3/0/0/7/0400970039/docs/970039_22_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 2 | /9/3/0/0/7/0400970039/docs/970039_24_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 3 | /9/3/0/0/7/0400970039/docs/970039_25_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 2 | /9/3/0/0/7/0400970039/docs/970039_26_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 4 | /9/3/0/0/7/0400970039/docs/970039_29_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 5 | /9/3/0/0/7/0400970039/docs/970039_33_incomingcorrespondencepaper20110110.pdf | ||
| 10/01/2011 | Incoming Correspondence Paper | Other | 1 | /9/3/0/0/7/0400970039/docs/970039_35_incomingcorrespondencepaper20110110.pdf | ||
| 12/02/1998 | Outgoing Correspondence | Outgoing Letter | 1 | /9/3/0/0/7/0400970039/docs/970039_0_outgoingcorrespondence19980212.pdf | ||
| 12/02/1998 | Outgoing Correspondence | Outgoing Letter | 1 | /9/3/0/0/7/0400970039/docs/970039_31_outgoingcorrespondence19980212.pdf |